Titratable Dosing in Moderate to Severe Asthmatics
Titratable Dosing in Moderate to Severe Asthmatics
The purpose of this study is to compare the long term safety of Symbicort with budesonide
 alone, in adolescents and adults with asthma.
Inclusion Criteria:

 -  Diagnosis of asthma and baseline lung function tests, symptoms and medication use as
 determined by the protocol

 -  Required and received treatment with inhaled corticosteroids within the timeframe and
 doses specified in the protocol

 Exclusion Criteria:

 -  Has required treatment with non-inhaled corticosteroids within previous 30 days, has
 sensitivity to drugs specified in the protocol or requires treatment with a
 beta-blocker.

 -  Has had cancer within previous 5 years or has a condition that may put the patient at
 risk in this study.